Category: Acad, Gov/Utilities
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue CARLSBAD, Calif., Dec. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients... Read more
Cancer Patients may get Faster and more Personalized Treatment as result of Collaboration between GE Healthcare, University of Cambridge and Addenbrooke’s hospital
Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by giving cancer care teams access to complex data and information The potentially transformative solution will initially focus on ovarian cancer and will then expand for use in breast and kidney cancer. Cambridge/Chalfont St Giles, UK;... Read more
GE Healthcare Receives FDA Clearance for First X-ray AI to Help Assess Endotracheal Tube Placement
Critical Care Suite 2.0 helps clinicians assess Endotracheal Tube (ETT) placement for intubated patients, including critical COVID-19 patients The AI suite also includes algorithms that help radiologists prioritize critical cases and automate processes to help cut average review time from up to eight hours1 CHICAGO – November 15, 2021 – GE Healthcare today announced it... Read more
Global Water Utilities Could Cut GHG Emissions by 50%, At Low to No Cost
New Paper Outlines Steps to Accelerate Sector’s Progress Toward Zero-Carbon Future RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 4, 2021– Global water utilities account for approximately 2% of greenhouse gas (GHG) emissions – the equivalent of the world’s shipping industry. And this figure is set to spiral as utilities work towards the UN’s Sustainable Development Goal of universal... Read more
FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)
Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with nAMD maintain their vision with as few as... Read more
Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)
Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1 The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study. This new test expands Roche’s... Read more
Walsh University and Shimadzu Scientific Instruments to Dedicate New Center for Analytical Excellence Laboratory for Advanced Chemical Analysis
Walsh University (North Canton, OH) and Shimadzu Scientific Instruments (SSI) will dedicate the Center for Analytical Excellence Laboratory, a collaborative project that includes the installation of nearly $1.2 million worth of new analytical equipment. This ongoing partnership was developed through the Shimadzu Partnership for Academics, Research and Quality of Life (SPARQ) program, which is designed... Read more
FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System
FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System CARLSBAD, Calif., Oct. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples collected with the... Read more